Publisher Future Science Group has announced the launch of the first issue of its new bimonthly title, CNS Oncology.
CNS Oncology will provide oncologists with updates on key issues in screening, diagnosis, imaging, surgery, radiation, chemotherapy, targeted therapeutics and palliative care by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal will take the lead in generating discourse and debate with the aim of improving outcome for brain tumor patients.
CNS Oncology is latest of Future Science Group's recent launches to focus on clinical cancer management and follows new titles for 2012, Breast Cancer Management and Lung Cancer Management. Another edition to this exciting portfolio, International Journal of Hematologic Oncology, will be launched in October.
Senior Editors, Henry S Friedman (Duke University Medical Center, USA) and Alba A Brandes (Azienda USL of Bologna, Italy), envisage the new addition to Future Science Group's portfolio will play a major role in disseminating current opinion on the treatment of patients with brain tumors to a broad constellation of physicians and scientists involved in the neuro-oncology field. The Senior Editors are supported by a team of six Associate Editors, together with an Advisory Panel of 32 international experts.
The Editorial Office is now actively soliciting contributions of original research, reviews and commentary articles for the journal. Clinical studies in any aspect of CNS oncology are encouraged.
